MAVS antibody (AA 477-505)

Catalog No. ABIN3031816

This Rabbit Polyclonal antibody specifically detects MAVS in WB and ELISA. It exhibits reactivity toward Human.

Quick Overview for MAVS antibody (AA 477-505) (ABIN3031816)

Target: MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This MAVS antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Product Details anti-MAVS Antibody

Binding Specificity: AA 477-505

Purpose: MAVS Antibody

Purification: Antigen affinity

Immunogen: A portion of amino acids 477-505 from the human protein was used as the immunogen for this MAVS antibody.

Isotype: Ig Fraction

Application Details

Application Notes: Titration of the MAVS antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Aliquot the MAVS antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for MAVS

Target: MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))

Alternative Name: MAVS

Background: Double-stranded RNA viruses are recognized in a cell type-dependent manner by the transmembrane receptor TLR3 or by the cytoplasmic RNA helicases MDA5 and RIGI. These interactions initiate signaling pathways that differ in their initial steps but converge in the activation of the protein kinases IKKA and IKKB which activate NFKB, or TBK1 and IKKE (IKBKE, MIM 605048), which activate IRF3. Activated IRF3 and NFKB induce transcription of IFNB. For the TLR3 pathway, the intermediary molecule before the pathways converge is the cytoplasmic protein TRIF. For RIGI, the intermediary protein is mitochondria-bound IPS1.

UniProt: Q7Z434

Pathways: Activation of Innate immune Response, Inositol Metabolic Process, Hepatitis C